Overview
Kazuko Hamamoto practices practicing medicine in Hiroshima, Japan.
Ms. Hamamoto is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Acute Megakaryoblastic Leukemia, Andersen Disease, Leukemia, and Hemophagocytic Lymphohistiocytosis.
She is actively involved in clinical research, co-authoring 21 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kazuko Hamamoto
Is Kazuko Hamamoto a top-rated expert for Acute Megakaryoblastic Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Kazuko Hamamoto is classified as an Advanced expert for Acute Megakaryoblastic Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kazuko Hamamoto participate in research or clinical trials?
Yes. Kazuko Hamamoto has published 21 articles and abstracts on conditions like Acute Megakaryoblastic Leukemia. You can view a list of Kazuko Hamamoto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Megakaryoblastic LeukemiaMs. Hamamoto isAdvanced. Learn about Acute Megakaryoblastic Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Ms. Hamamoto isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloid Leukemia (AML)Ms. Hamamoto isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaMs. Hamamoto isExperienced. Learn about Acute Promyelocytic Leukemia.
- Andersen DiseaseMs. Hamamoto isExperienced. Learn about Andersen Disease.
- Chronic Myelogenous Leukemia (CML)Ms. Hamamoto isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Hemophagocytic LymphohistiocytosisMs. Hamamoto isExperienced. Learn about Hemophagocytic Lymphohistiocytosis.
- HistiocytosisMs. Hamamoto isExperienced. Learn about Histiocytosis.
- LeukemiaMs. Hamamoto isExperienced. Learn about Leukemia.
- Non-Langerhans-Cell HistiocytosisMs. Hamamoto isExperienced. Learn about Non-Langerhans-Cell Histiocytosis.
- ReticulohistiocytomaMs. Hamamoto isExperienced. Learn about Reticulohistiocytoma.